(CLB)

Role: Director
Signature: /s/ Mark D. Tattoli, Attorney-in-Fact
Issuer symbol: CLB
Transactions as of: 28 Jun 2023
Net transactions value: $0
Form type: 3
Filing time: 07 Jul 2023, 12:51:22 UTC
Previous filing: 28 Apr 2023
Next filing: 07 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CLB	Common Shares						0	28 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CLB	Restricted Shares							28 Jun 2023	Common Shares	6,419	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Shares were granted to Mr. Anastasio upon his election to the Board of Directors of Core Laboratories Inc., as part of the annual grant given to all non-executive directors on April 1, 2023, and will vest, without performance criteria, on April 1, 2024, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.

Content

The Restricted Shares were granted to Mr. Anastasio upon his election to the Board of Directors of Core Laboratories Inc., as part of the annual grant given to all non-executive directors on April 1, 2023, and will vest, without performance criteria, on April 1, 2024, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.